Trials / Completed
CompletedNCT03626207
Development of Visual Function Evaluation Method (2)
Calibration of Visual Function Evaluation Tests in Patients With Severe Vision Loss
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient.
Conditions
Timeline
- Start date
- 2018-10-04
- Primary completion
- 2019-06-26
- Completion
- 2019-06-26
- First posted
- 2018-08-10
- Last updated
- 2024-10-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03626207. Inclusion in this directory is not an endorsement.